期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

缺血性脑血管病神经保护治疗的研究进展

Advance on the protective treatment of ischemic cerebral vascular and nervers injury
暂未订购
导出
摘要 缺血性脑血管病发病后造成血管病损和神经元损伤致死亡的病理机制是多元的,如Ca2+超载和兴奋性氨基酸增多,也涉及NO、自由基、腺苷、多巴胺、5-HT、钾通道及磷酸二酯酶的异常改变.其中,以Ca2+超载及兴奋性氨基酸为主要病理变化.近几年来,人们对缺血性脑血管病造成脑损伤的研究取得了较大进展,并针对脑损伤的病因及病理机制进行了研究,提出了多种治疗方向和方法.
作者 李菁
机构地区 北京世纪坛医院
出处 《临床药物治疗杂志》 2005年第6期16-20,10,共6页 Clinical Medication Journal
关键词 缺血性脑血管病 神经保护 脑损伤 脑血流量 雌激素 阿司匹林
分类号 R743.31 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献35

  • 1[1]Matsuda T,Ankacrona N,Gakuma K,et al. SEAO400,a novel and selective inhibitor of the Na + Ca2 + exchanger,attenuates reperfusion injury in vitro and in vivo cerebral ischemic models. J Pharmacol Exp ,2001,298 ( 1 ) :249 ～ 256
  • 2[2]Rod MR, Auer RN, et al. Combination therapy with nimodipine and dizocilpine in a rat model of transient forebrain ischemia.Stroke, 1992,23 ( 5 ) :725 ～ 732
  • 3[3]Kobayashi T, Mori Y. Ca2 + channel antagonists and neuroprotection from cerebral is chemia. Eur J Pharmacol, 1998,363 ( 1 ): 1～ 15
  • 4[4]Zapater P, Moreno J, Horga JF. Neuroprotection by the novel calcium antagonist PCAS0938, nimodipine and flunarizine, in gerbilglobal brain ischemia. Brain Res, 1997,772 ( 1 ～ 2 ) :57 ～ 62
  • 5[5]Frandsen A, Schousboe A. Dantrolene prevents glutamate cytotoxiiicity and Ca + + release from intracellular stores in cultured cerebral cortical neurons. J Neurochem, 1991,56 ( 3 ): 1075 ～ 1078
  • 6[6]Mody I, Mac Donald JF. NMDA receptor - dependent excitotoxicity: the role of innntracellular Ca2+ release. Trends Pharmacol Sci, 1995,16(10) :356 ～ 359
  • 7[7]Smith SE, Meldrum BS. Cerebroprotective effect of a non - N methyl - aspartete antagonist, GYKI 52466, after focal ischemia in the rat. Stroke, 1992,23 ( 6 ) :861 ～ 864
  • 8[8]Li ZZ. Progress in glutamate and antitoxicity of glutamate in cerebralischemia.Foreign Med Sci Sect Cerebralvasc Dis(国外医学脑血管病分册),1995,3(4):171～174
  • 9[9]Lysko,PG;Yue TL,Gu JL,Feuerstein G. Neuroprotective mechanism of ( + )SKF10047 in vitro and in gerbil global brain ischemia. Stroke, 1992,23 (9): 1324
  • 10[10]Schmid - Elsaesser R, Hungerhuber E,Zausinger S,et al. Neuroprotective effects of novel brain - penetrating antioxidant U 101033E and spin - trapping agent alpha - phenyl - N - tert butyl nitrone(PBN). Exp Brain Res ,2000,130( 1 ) :60 ～ 66

二级参考文献22

  • 1Zhang S，Mol Brain Res，1998年，63卷，1期，121页
  • 2Wang C Y，Science，1998年，282卷，5383期，1680页
  • 3Wang C Y，Science，1996年，274卷，5288期，784页
  • 4Thorne RG,Frey WH.Delivery of neurotrophic factors to the central nervous system.Clin pharmacokinet,2001,40: 907-946.
  • 5Fisher M,Meadows ME,Do T,et al.Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats.J Cereb Blood Flow Metab,1995,15:953-959.
  • 6Schroeder U,Sommerfeld P,Ulrich S,et al.Nanoparticle technology for delivery of drugs across the Blood-Brain Barrier.J Pharm Sci,1998,87:1305-1307.
  • 7Cedarbaum JM,Chapman C,Charatan M,et al.A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis.ALS CNTF Treatment Study Group.Neurology,1996,46: 1244-1249.
  • 8Petty BG,Cornblath DR,Adornato BT,et al.The effect of systemically administered recombinant human nerve growth factor in healthy human subjects.Ann Neurol ,1994,36:244-246.
  • 9Yan Q,Matheson C,Sun J,et al.Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with Trk receptor expression.Exp Neurol,1994,127: 23-36.
  • 10Dittrich F,Ochs G,Grobe-Wilde A,et al. Pharmacokinetics of intrathecally applied BDNF and effects on spinal motoneurons. Exp Neurol,1996,141: 225-239.

共引文献2

临床药物治疗杂志
2005年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部